Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Healthcare Drug Manufacturers - Major
Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

Elixxer Ltd.
Bullboard Posts
User Avatar Image
(2)
•••
Post by Kenny1000on Nov 21, 2017 2:04pm
163 Views
Post# 27005247

produce export-quantities of high-grade medical cannabis...

produce export-quantities of high-grade medical cannabis...In 2015, in partnership with the South African Departments of Agriculture and Health, the University of the Free State, and the Council of Scientific and Industrial Research (CSIR), HOH began conducting research into medical Cannabis. Our focus is on CBD strains, which they cultivate and process at Dube Agrizone in our 40 000 m2 of greenhouse space.

The medical potential there is extremely exciting, and they were privileged to be on the leading edge of this growing movement.
HOUSE OF HEMP PARTNERS WITH AFRIAG & LGC

On July 18, 2017, House of Hemp sold a 60% interest to Canadian venture capital firm LGC, and its strategic partner in Africa, AfriAg. With the additional resources of this partnership, they will be focusing on increasing their growing footprint at Dube, so as to produce export-quantities of high-grade medical cannabis.

https://www.samusicnews.co.za/2017/10/26/cannabis-queen-south-thandeka-ruth-kunene-house-hemp/
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities